| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Department of Pathology, Harvard Medical School, Boston, MA 02115; and
Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115
Blocking the interaction of the CD28 costimulatory receptor with its ligands, CD80 and CD86, inhibits in vivo immune responses, such as allograft rejection, and in some instances induces tolerance. Previously, we found that CTLA4Ig, which blocks the CD28/CTLA-4 (CD152) ligands CD80 and CD86, can be used to induce transplantation tolerance to vascularized allografts. Recent data suggest that an intact CD152-negative signaling pathway is essential for induction of tolerance to nominal Ags. Here, we show that blockade of CD152 using an anti-CD152 mAb at the time of transplantation prevents the induction of long-term allograft survival by agents that target CD80 and CD86. In contrast, CD152 signals are not required for the maintenance of established graft survival. We also report for the first time that blockade of CD86 alone can induce long-term graft survival. This requires that anti-CD86 mAb is given on the day of transplantation and also depends upon an intact CD152 pathway. This result, plus experiments using CD80-deficient mice, suggests a dominant role for CD80 molecules on donor cells as the relevant ligand for CD152. We additionally find that blockade of CD152 at the time of transplantation does not interfere with the effectiveness of anti-CD154 mAbs, suggesting distinct mechanisms for inhibition of graft rejection by blocking the CD28 vs CD154 pathways.
This article has been cited by other articles:
|
|
 |
|
  P. I. Lobo, K. H. Schlegel, C. E. Spencer, M. D. Okusa, C. Chisholm, N. Mchedlishvili, A. Park, C. Christ, and C. Burtner Naturally Occurring IgM Anti-Leukocyte Autoantibodies (IgM-ALA) Inhibit T Cell Activation and Chemotaxis J. Immunol., February 1, 2008; 180(3): 1780 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, C. K. Chang, T. Hayden, F.-C. Liu, J. Benjamin, J. A. Hamerman, L. L. Lanier, and S.-M. Kang The Activating Immunoreceptor NKG2D and Its Ligands Are Involved in Allograft Transplant Rejection J. Immunol., November 15, 2007; 179(10): 6416 - 6420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. A. Coenen, H. J. P. M. Koenen, E. van Rijssen, L. Boon, I. Joosten, and L. B. Hilbrands CTLA-4 Engagement and Regulatory CD4+CD25+ T Cells Independently Control CD8+-Mediated Responses under Costimulation Blockade J. Immunol., May 1, 2006; 176(9): 5240 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lin, Z. Liang, Y. Chen, and Y. Zeng TLR3-Involved Modulation of Pregnancy Tolerance in Double-Stranded RNA-Stimulated NOD/SCID Mice J. Immunol., April 1, 2006; 176(7): 4147 - 4154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. O. Salvalaggio, G. Camirand, C. E. Ariyan, S. Deng, L. Rogozinski, G. P. Basadonna, and D. M. Rothstein Antigen Exposure during Enhanced CTLA-4 Expression Promotes Allograft Tolerance In Vivo J. Immunol., February 15, 2006; 176(4): 2292 - 2298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, K. K. Dhanireddy, and A. D. Kirk Human Monocytes as Intermediaries between Allogeneic Endothelial Cells and Allospecific T Cells: A Role for Direct Scavenger Receptor-Mediated Endothelial Membrane Uptake in the Initiation of Alloimmunity J. Immunol., January 15, 2006; 176(2): 750 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Izawa, K. Sano, M. Takehara, M. Inobe, J.-i. Suzuki, H. Imamura, M. Takahashi, U. Ikeda, M. Isobe, and T. Uede Cre/loxP-mediated CTLA4IgG gene transfer induces clinically relevant immunosuppression via on-off gene recombination in vivo Cardiovasc Res, January 1, 2006; 69(1): 289 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Hosiawa, H. Wang, M. E. DeVries, B. Garcia, W. Liu, D. Zhou, A. Akram, J. Jiang, H. Sun, M. J. Cameron, et al. CD80/CD86 Costimulation Regulates Acute Vascular Rejection J. Immunol., November 1, 2005; 175(9): 6197 - 6204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sho, K. Kishimoto, H. Harada, M. Livak, A. Sanchez-Fueyo, A. Yamada, X. X. Zheng, T. B. Strom, G. P. Basadonna, M. H. Sayegh, et al. Requirements for induction and maintenance of peripheral tolerance in stringent allograft models PNAS, September 13, 2005; 102(37): 13230 - 13235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Quezada, K. Bennett, B. R. Blazar, A. Y. Rudensky, S. Sakaguchi, and R. J. Noelle Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation J. Immunol., July 15, 2005; 175(2): 771 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mirenda, D. Golshayan, J. Read, I. Berton, A. N. Warrens, A. Dorling, and R. I. Lechler Achieving Permanent Survival of Islet Xenografts by Independent Manipulation of Direct and Indirect T-Cell Responses Diabetes, April 1, 2005; 54(4): 1048 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Sandner, M. R. Clarkson, A. D. Salama, A. Sanchez-Fueyo, C. Domenig, A. Habicht, N. Najafian, H. Yagita, M. Azuma, L. A. Turka, et al. Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo J. Immunol., March 15, 2005; 174(6): 3408 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gur, R. Krauthgamer, E. Bachar-Lustig, H. Katchman, R. Arbel-Goren, A. Berrebi, T. Klein, A. Nagler, A. Tabilio, M. F. Martelli, et al. Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-{alpha} Blood, March 15, 2005; 105(6): 2585 - 2593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamada, A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, et al. CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo J. Immunol., February 1, 2005; 174(3): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-Y. Zhu, Y.-H. Zhou, M.-Y. Wang, L.-P. Jin, M.-M. Yuan, and D.-J. Li Blockade of CD86 Signaling Facilitates a Th2 Bias at the Maternal-Fetal Interface and Expands Peripheral CD4+CD25+ Regulatory T Cells to Rescue Abortion-Prone Fetuses Biol Reprod, February 1, 2005; 72(2): 338 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Watson, G. Y. Zhang, M. Sartor, and S. I. Alexander "Pruning" of Alloreactive CD4+ T Cells Using 5- (and 6-)Carboxyfluorescein Diacetate Succinimidyl Ester Prolongs Skin Allograft Survival J. Immunol., December 1, 2004; 173(11): 6574 - 6582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zheng, C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells J. Immunol., March 1, 2004; 172(5): 2778 - 2784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ariyan, P. Salvalaggio, S. Fecteau, S. Deng, L. Rogozinski, D. Mandelbrot, A. Sharpe, M. H. Sayegh, G. P. Basadonna, and D. M. Rothstein Cutting Edge: Transplantation Tolerance through Enhanced CTLA-4 Expression J. Immunol., December 1, 2003; 171(11): 5673 - 5677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Elhalel, J.-H. Huang, W. Schmidt, J. Rachmilewitz, and M. L. Tykocinski CTLA-4 {middle dot} FasL Induces Alloantigen-Specific Hyporesponsiveness J. Immunol., June 15, 2003; 170(12): 5842 - 5850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yin, N. Dujovny, L. Ma, A. Varghese, J. Shen, D. K. Bishop, and A. S. Chong IFN-{gamma} Production Is Specifically Regulated by IL-10 in Mice Made Tolerant with Anti-CD40 Ligand Antibody and Intact Active Bone J. Immunol., January 15, 2003; 170(2): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Pistillo, P. L. Tazzari, G. L. Palmisano, I. Pierri, A. Bolognesi, F. Ferlito, P. Capanni, L. Polito, M. Ratta, S. Pileri, et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells Blood, January 1, 2003; 101(1): 202 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size J. Immunol., October 1, 2002; 169(7): 3744 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shirasugi, A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen Prevention of Chronic Rejection in Murine Cardiac Allografts: A Comparison of Chimerism- and Nonchimerism-Inducing Costimulation Blockade-Based Tolerance Induction Regimens J. Immunol., September 1, 2002; 169(5): 2677 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Trzonkowski, J. Mysliwska, A. Debska-Slizien, E. Bryl, D. Rachon, A. Mysliwski, and B. Rutkowski Long-term therapy with recombinant human erythropoietin decreases percentage of CD152+ lymphocytes in primary glomerulonephritis haemodialysis patients Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1070 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamada, A. D. Salama, and M. H. Sayegh The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575. [Full Text] [PDF]
|
|
|
|
|
|
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo J. Immunol., November 1, 2001; 167(9): 4936 - 4941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamada, K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, et al. CD28-independent Costimulation of T Cells in Alloimmune Responses J. Immunol., July 1, 2001; 167(1): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Blass, E. Pure, and C. A. Hunter A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii J. Immunol., May 1, 2001; 166(9): 5726 - 5732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Wu, A. Q. Khan, Y. Shen, J. Schartman, R. Peach, A. Lees, J. J. Mond, W. C. Gause, and C. M. Snapper B7 Requirements for Primary and Secondary Protein- and Polysaccharide-Specific Ig Isotype Responses to Streptococcus pneumoniae J. Immunol., December 15, 2000; 165(12): 6840 - 6848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pioli, L. Gatta, V. Ubaldi, and G. Doria Inhibition of IgG1 and IgE Production by Stimulation of the B Cell CTLA-4 Receptor J. Immunol., November 15, 2000; 165(10): 5530 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. TOMASONI, N. AZZOLLINI, F. CASIRAGHI, M. C. CAPOGROSSI, G. REMUZZI, and A. BENIGNI CTLA4Ig Gene Transfer Prolongs Survival and Induces Donor-Specific Tolerance in a Rat Renal Allograft J. Am. Soc. Nephrol., April 1, 2000; 11(4): 747 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction J. Immunol., March 15, 2000; 164(6): 2987 - 2993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sakurai, J. Ohata, K. Saito, H. Miyajima, T. Hirano, T. Kohsaka, S. Enomoto, K. Okumura, and M. Azuma Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells J. Immunol., January 15, 2000; 164(2): 664 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Iwakoshi, J. P. Mordes, T. G. Markees, N. E. Phillips, A. A. Rossini, and D. L. Greiner Treatment of Allograft Recipients with Donor-Specific Transfusion and Anti-CD154 Antibody Leads to Deletion of Alloreactive CD8+ T Cells and Prolonged Graft Survival in a CTLA4-Dependent Manner J. Immunol., January 1, 2000; 164(1): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Liang, R. J. Gee, M. J. Kashgarian, A. H. Sharpe, and M. J. Mamula B7 Costimulation in the Development of Lupus: Autoimmunity Arises Either in the Absence of B7.1/B7.2 or in the Presence of Anti-B7.1/B7.2 Blocking Antibodies J. Immunol., August 15, 1999; 163(4): 2322 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. GUDMUNDSDOTTIR and L. A. TURKA T Cell Costimulatory Blockade: New Therapies for TransplantRejection J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1356 - 1365. [Abstract] [Full Text]
|
|
|
|
|
|
F. Luhder, C. Chambers, J. P. Allison, C. Benoist, and D. Mathis Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells PNAS, October 24, 2000; 97(22): 12204 - 12209. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
